Format

Send to

Choose Destination
See comment in PubMed Commons below
Ir J Med Sci. 2010 Dec;179(4):535-7. doi: 10.1007/s11845-010-0527-x. Epub 2010 Jul 31.

Secondary prevention for coronary artery disease: are we following the guidelines?

Author information

1
Waterford Regional Hospital, Waterford, Ireland. asimsyed01@hotmail.com

Abstract

BACKGROUND:

Secondary prevention pharmacotherapy in post-myocardial infarction (MI) patients reduces the risk of subsequent coronary events and overall mortality. International guidelines recommend use of aspirin, beta-blockers, ACE inhibitors and statins in post-MI patients.

AIMS:

We performed this audit to review the compliance of prescribing practices, in a regional hospital in Ireland, with international guidelines for secondary prevention of coronary artery disease.

METHODS:

We performed a retrospective case review of 172 patients diagnosed with MI during a 1-year period between January and December 2007.

RESULTS:

A total of 134 patients fulfilled the inclusion criteria. On discharge, aspirin was prescribed to 131 (97.76%) patients, clopidogrel to 126 (94%), beta-blockers to 117 (87%), ACE inhibitor to 87 (65%), ARB to 10 (7%) and statins to 116 (87%).

CONCLUSION:

Our audit shows that targets for prescription of secondary prevention medications were not met in a small but significant proportion of patients and calls for review of discharge practices and education to improve compliance with guidelines.

PMID:
20676796
DOI:
10.1007/s11845-010-0527-x
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Support Center